| mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |